Your browser doesn't support javascript.
loading
Clinical Characteristics of Recurrent-positive Coronavirus Disease 2019 after Curative Discharge: a retrospective analysis of 15 cases in Wuhan China
Lan Chen; Zhen-Yu Zhang; Xiao-Bin Zhang; Su-Zhen Zhang; Qiu-Ying Han; Zhi-Peng Feng; Jian-Guo Fu; Xiong Xiao; Hui-Min Chen; Li-Long Liu; Xian-Li Chen; Yu-Pei Lan; De-Jin Zhong; Lan Hu; Jun-Hui Wang; Zhen-Yu Yin.
Afiliação
  • Lan Chen; Zhongshan Hospital, Xiamen University
  • Zhen-Yu Zhang; Zhongshan Hospital, Xiamen University
  • Xiao-Bin Zhang; Zhongshan Hospital, Xiamen University
  • Su-Zhen Zhang; Zhongshan Hospital, Xiamen University
  • Qiu-Ying Han; Zhongshan Hospital, Xiamen University
  • Zhi-Peng Feng; Zhongshan Hospital, Xiamen University
  • Jian-Guo Fu; Zhongshan Hospital, Xiamen University
  • Xiong Xiao; Xiamen Branch of Zhongshan Hospital Affiliated to Fudan University
  • Hui-Min Chen; Xiamen Third Hospital
  • Li-Long Liu; Hongai Hospital, Xiamen
  • Xian-Li Chen; Xiang'an Hospital Affiliated to Xiamen University
  • Yu-Pei Lan; Xiamen Haicang Hospital
  • De-Jin Zhong; Xiamen Changgen Hospital
  • Lan Hu; Optics Valley Branch of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan
  • Jun-Hui Wang; Optics Valley Branch of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan
  • Zhen-Yu Yin; Zhongshan Hospital, Xiamen University
Preprint em Inglês | medRxiv | ID: ppmedrxiv-20144873
ABSTRACT
In China, the patients with previously negative RT-PCR results again test positive during the post-discharge isolation period. We aimed to determine the clinical characteristics of these "recurrent-positive" patients. We retrospectively reviewed the data of 15 recurrent-positive patients and 107 control patients with non-recurrent, moderate COVID-19 treated in Wuhan, China. Clinical data and laboratory results were comparatively analyzed. We found that recurrent-positive patients had moderate disease. The rate of recurrent-positive disease in our hospital was 1.87%. Recurrent-positive patients were significantly younger (43(35-54) years) than control patients (60(43-69) years) (P=0.011). The early LOS (length of stay in hospital before recurrence) was significantly longer in recurrent-positive patients (36(34-45) days) than in control patients (15(7-30) days) (P =0.001). The time required for the first conversion of RT-PCR results from positive to negative was significantly longer in recurrent-positive patients (14(10-17) days) than in control patients (6(3-9) days) (P =0.011). Serum COVID-19 antibody levels were significantly lower in recurrent-positive patients than in control patients (IgM 13.69 {+/-} 4.38 vs. 68.10 {+/-} 20.85 AU/mL, P = 0.015; IgG 78.53 {+/-} 9.30 vs. 147.85 {+/-} 13.33 AU/mL, P < 0.0001). Recurrent-positive patients were younger than control patients. The early LOS (length of stay in hospital before recurrence) was significantly longer in recurrent-positive group than that in control group. COVID-19 IgM/IgG antibody levels were significantly lower in recurrent-positive group than those in control group, which might explain why the virus RNA RT-PCR was positive after the initial "clinical cure"(with three times of virus RNA RT-PCR negative). The virus might not be fully eliminated because of the lower IgG level and their later replicating might result in recurrent-positive virus RNA RT-PCR.
Licença
cc_no
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Experimental_studies / Estudo observacional / Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Experimental_studies / Estudo observacional / Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...